Disclaimer. This site is a training resource for oncology data specialists and cancer registration trainees. It is not intended to provide medical advice or to guide clinical care, diagnosis, or treatment. NCI urges users to consult with a qualified physician for diagnosis and for answers to their personal medical questions.

Providing web-based training modules for cancer registration and surveillance

Genomic Testing

Gene profile testing, which is done by microarray assay or reverse transcription-polymerase chain, is done to help with treatment decisions and is part of precision medicine.

There is no standard genomic testing at this time for bladder. There is a controversial testing for the DPYD gene and its effects on the dosing of some of the chemotherapeutic agents.

Updated: April 22, 2025

Suggested Citation

SEER Training Modules: Genomic Testing. U.S. National Institutes of Health, National Cancer Institute. Cited 30 December 2025. Available from: https://training.seer.cancer.gov.

Genomic Testing

Suggested Citation

Glossary Term